drugset / Trial / NCT03905811
A Pilot Study of Terazosin for Parkinson's Disease
RandomizedParallel-groupTriple-blindTreatment
Summary
The TZ-PD trial will be a 1:1 (active:placebo) randomized, double-blind, placebo-controlled Phase II trial to evaluate the safety and tolerability of terazosin for the treatment of PD.
Timeline
- Start
- 2019-09-24
- Primary completion
- 2020-06-05
- Completion
- 2020-11-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Terazosin | Small molecule | 5 mg | Oral |